Board logo

标题: GWD8-Q4 [打印本页]

作者: swinerton    时间: 2009-10-12 06:48     标题: GWD8-Q4

Frazier and Mosteller assert that medical research could be improved by a move toward larger, simpler clinical trials of medical treatments. Currently, researchers collect far more background information on patients than is strictly required for their trials—substantially more than hospitals collect—thereby escalating costs of data collection, storage, and analysis. Although limiting information collection could increase the risk that researchers will overlook facts relevant to a study, Frazier and Mosteller contend that such risk, never entirely eliminable from research, would still be small in most studies. Only in research on entirely new treatments are new and unexpected variables likely to arise.

        Frazier and Mosteller propose not only that researchers limit data collection on individual patients but also that researchers enroll more patients in clinical trials, thereby obtaining a more representative sample of the total population with the disease under study. Often researchers restrict study participation to patients who have no ailments besides those being studied. A treatment judged successful under these ideal conditions can then be evaluated under normal conditions. Broadening the range of trial participants, Frazier and Mosteller suggest, would enable researchers to evaluate a treatment’s efficacy for diverse patients under various conditions and to evaluate its effectiveness for different patient subgroups. For example, the value of a treatment for a progressive disease may vary according to a patient’s stage of disease. Patients’ ages may also affect a treatment’s efficacy.

GWD-8-Q4 :

According to the passage, Frazier and Mosteller believe which of the following about medical research?

A.    It is seriously flawed as presently conducted because researchers overlook facts that are relevant to the subject of their research.

B.    It tends to benefit certain subgroups of patients disproportionately.

C.    It routinely reveals new variables in research on entirely new treatments.

D.    It can be made more accurate by limiting the amount of information researchers collect.

E.     It cannot be freed of the risk that significant variables may be overlooked.

答案:E。这个E我是明白的。但是不明白为什么B选项不正确。因为在全文的最后部分有这样的一段话:Broadening the range of trial participants, Frazier and Mosteller suggest, would enable researchers to evaluate a treatment’s efficacy for diverse patients under various conditions and to evaluate its effectiveness for different patient subgroups.这个难道没有暗示B是正确的吗?请nn多多指教哦:)


作者: dowecho    时间: 2009-10-13 06:46

这道题我还觉得C)对呢,E)里面的significant并没有在文章中有提到过。
作者: jjapollo    时间: 2009-10-13 20:36

C不对吧,routinely是说例行公事的,应该可以理解成有new treatments就会有new virables吧,但文中只是说

Only in research on entirely new treatments are new and unexpected variables likely to arise.可能


作者: happylulu_li    时间: 2009-12-14 15:24

但是E中的significant也不对啊,文中只说是relevant

 the risk that researchers will overlook facts relevant to a study, Frazier and Mosteller contend that such risk, never entirely eliminable from research






欢迎光临 国际顶尖MBA申请交流平台--TOPWAY MBA (http://forum.topway.org/) Powered by Discuz! 7.2